FDA’s Proposed Order For Sunscreens, A First Under OTC Reforms, Reprises 2019 Proposed Rule

As anticipated, the US FDA’s proposed order for sunscreens released on 24 September creates a bridge to the agency’s 2019 proposed rule before the CARES Act overhauled OTC drug review in March 2020.

Sun screen

The US Food and Drug Administration’s 24 September proposed order to amend the OTC sunscreen drug monograph provides a first look at the new administrative – versus rulemaking – process for OTC drug review under reforms achieved through COVID relief legislation last year.

Acting FDA commissioner Janet Woodcock states in a same-day release, “Today's activities represent a key milestone in our implementation of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America